![]() ![]() ![]() The Medicines and Healthcare products Regulatory Agency (MHRA) approved the trial in December 2020, with its first phase that took place at Hammersmith Medicines Research (HMR) now complete. MAC Clinical Research – one of Europe's largest independent clinical development firms - has been selected by neuropharmaceutical company Small Pharma to accelerate research for its lead product dimethyltryptamine - and test for its effectiveness in major depressive disorder (MDD). ![]() A North West firm has been chosen to co-lead research into a new psychedelic drug treatment for depression. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |